Tech: Amgen scientists work at the company’s Thousand Oaks headquarters. Thousand Oaks-based pharma giant Amgen Inc. said it would lay off approximately 450 employees, or nearly 2% of its workforce, ...

In January, Amgen laid off about 300 employees as part of organizational changes, which "mainly" impacted the U.S.-based commercial team. "We made these changes to better manage against industry ...

Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26.

Amgen is laying off more workers in Ventura County. The bio-pharmaceutical giant said March 16 that it will eliminate about 450 jobs, or less than 2% of its global workforce. That’s on top of 305 cuts ...

We aren’t trying to monopolize nature.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amgen To Contact Him Directly To Discuss Their Options New York, New York ...

The Supreme Court appeared to struggle Monday over Amgen Inc.'s arguments in a dispute with Sanofi S.A. that two canceled ...

Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.

Amgen reported solid results for fiscal 2022 with the bottom line growing in the double digits. The company recently announced the acquisition of Horizon Therapeutics and while the acquisition ...

March 27 (Reuters) - Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ...

In the latest trading session, Amgen (AMGN) closed at $238.48, marking a +0.73% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.16%. Meanwhile, the Dow lost 0.12% ...